CRT 2019: Renal denervation using alcohol “seems very effective”

The renal denervation bubble collapsed due to a single trial—SYMPLICITY HTN-3, but this trial’s findings went against the grain, Horst Sievert (Frankfurt, Germany) tells Cardiovascular News at CRT 2019. Sievert shares early results of alcohol-mediated renal denervation, which were presented as a late-breaking abstract at the conference.

Sievert, Horst

Horst Sievert (Frankfurt, Germany), is the Director of the CardioVascular Center Frankfurt, Sankt Katharinen, and the Department of Internal Medicine, Cardiology, and Vascular Medicine of the Sankt Katharinen Hospital in Frankfurt, Germany. He is also an Associate Professor of Internal Medicine/Cardiology at the University of Frankfurt.

Add comment

Editor’s Cardiovascular Pick

    Subscribeto receive the very best in medical videos